The metropolitan atlanta congenital defects program: 35 Years of birth defects surveillance at the centers for disease control and prevention

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 67, Issue 9, 2003, Pages 617-624

  Correa Villaseñor, Adolfo ^a,b   Cragan, Janet ^a   Kucik, James ^a   O'Leary, Leslie ^a   Siffel, Csaba ^a   Williams, Laura ^a  

^a National Center for Birth Defects and Developmental Disabilities   (United States)

^b The National Center on Birth Defects   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID; MULTIVITAMIN;

ANALYTIC METHOD; ARTICLE; BIRTH DEFECT; DRUG UTILIZATION; EVALUATION; FEVER; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; INFORMATION PROCESSING; MATERNAL DIABETES MELLITUS; NEURAL TUBE DEFECT; ORGANIZATION; PATIENT CODING; PATIENT MONITORING; POPULATION RESEARCH; PRENATAL EXPOSURE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; REGISTER; RISK FACTOR; SURVIVAL RATE; TECHNIQUE; UNITED STATES; VITAMIN SUPPLEMENTATION; WAR;

2,4,5-TRICHLOROPHENOXYACETIC ACID; 2,4-DICHLOROPHENOXYACETIC ACID; ABNORMALITIES; CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); DEFOLIANTS, CHEMICAL; DIABETES MELLITUS; ENVIRONMENTAL EXPOSURE; FOLIC ACID; FORMS AND RECORDS CONTROL; GEORGIA; MEDICAL RECORDS; NEURAL TUBE DEFECTS; PROGNOSIS; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; SEIZURES, FEBRILE; SENTINEL SURVEILLANCE; TETRACHLORODIBENZODIOXIN; UNITED STATES; URBAN POPULATION; VETERANS; VITAMINS;

EID: 0141864516     PISSN: 15420752     EISSN: None     Source Type: Journal    
DOI: 10.1002/bdra.10111     Document Type: Article

References (76)

1. Araneta MR, Moore CA, Olney RS, Edmonds LD, Karcher JA, McDonough C, Hiliopoulos KM, Schlangen KM, Gray GC. 1997. Goldenhar syndrome among infants born in military hospitals to Gulf War veterans. Teratology 56:244-251.
2. Becerra JE, Khoury MJ, Cordero JF, Erickson JD. 1990. Diabetes mellitus during pregnancy and the risks for specific birth defects: a population-based case-control study. Pediatrics 85:1-9.
3. Berry RJ, Li Z, Erickson JD, Li S, Moore, CA, Wang H, Mulinare J, Zhao P, Wong L-Y, Gindler J, Hong S-X, Correa A. 1999. Preventing neural tube defects with folic acid in the People's Republic of China. N Engl J Med 341:1485-1490.
4. Botto LD, Khoury MJ, Mulinare J, Erickson JD. 1996. Periconceptional multivitamin use and the occurrence of conotruncal heart defects: results from a population-based case-control study. Pediatrics 98:911-917.
5. Botto LD, Correa A, Erickson JD. 2001. Racial and temporal variations in the prevalence of heart defects. Pediatrics 107:E32.
6. Botto LD, Lynberg MC, Erickson JD. 2001. Congenital heart defects, maternal febrile illness, and multivitamin use: a population-based study. Epidemiology 12:485-490.
7. Bower C, Stanley FJ. 1989. Dietary folate as a risk factor for neural-tube defects: evidence from a case-control study in Western Australia. Med J Austr 150:613-619.
8. British Paediatric Association. 1979. British Paediatric Association Classification of Diseases. London: British Paediatric Association.
9. CDC. 1973. Epidemiologic notes and reports: spray adhesives, birth defects, and chromosomal damage. MMWR 22:365-366.
10. CDC. 1979. Temporal trends in the incidence of birth defects. MMWR 28:401-402.
11. CDC. 1981. Ventricular septal defect. MMWR 30:609-611.
12. CDC. 1984. Vietnam veterans' risks for fathering babies with birth defects. MMWR 33:457-459.
13. CDC. 1988. Periconceptional use of multivitamins and the occurrence of anencephaly and spina bifida. MMWR 37:727-730.
14. CDC. 1998. Trends in infant mortality attributed to birth defects-United States, 1980-1995. MMWR 47:773-778.
15. CDC. 1989. Metropolitan Atlanta Congenital Defects Program Procedures Manual, Atlanta, Georgia.
16. CDC. 1992. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR 41(RR-4):1-7.
17. CDC. 1993. Pregnancy outcomes following systemic prenatal acyclovir exposure - June 1, 1984 to June 30, 1993. MMWR 42:806-809.
18. CDC. 1995. Chorionic villus sampling and amniocentesis; recommendations for prenatal counseling. MMWR 44:1-12.
19. CDC. 2000. State birth defects surveillance programs directory. Teratology 61:33-85.
20. Chavez GF, Mulinare J, Cordero JF. 1989. Maternal cocaine use during early pregnancy as a risk factor for congenital urogenital anomalies. JAMA 262:795-798.
21. Cochi SL, Edmonds LD, Dyer K, Greaves WL, Marks JS, Rovira, EZ, Preblud SR, Orenstein WA. 1989. Congenital rubella syndrome in the United States, 1970-1985. On the verge of elimination. Am J Epidemiol 129:349-361.
22. Correa A, Botto L, Liu Y, Mulinare J, Erickson JD. 2003. Do multivitamin supplements attenuate the risk of diabetes-associated birth defects? Pediatrics 111;1146-1151.
23. Edmonds LD, Layde PM, Erickson JD. 1979. Airport noise and teratogenesis. Arch Environ Health 34:243-247
24. Edmonds LD, Layde PM, James LM, Flynt JW, Erickson JD, Oakley GP Jr. 1981. Congenital malformations surveillance: two American systems. Int J Epidemiol 10:247-252.
25. Erickson JD, Oakley GP Jr., Flynt JW Jr., Hay S. 1976. Water fluoridation and congenital malformations: no association. J Am Dent Assoc 93:981-984.
26. Erickson JD, Mulinare J, McClain PW, Fitch TG, James LM, McClearn AB, Adams MJ. 1984. Vietnam veterans' risk for fathering babies with birth defects. JAMA 252:903-912.
27. Food and Drug Administration. 1996. Food Standards. Federal Register 61:8781-8797.
28. Hall JG, Powers EK, McIlavaine. 1978. The frequency and financial burden of genetic disease in a pediatric hospital. Am J Med Genetic 1:417-436.
29. Honein MA, Paulozzi LJ. 1999. Birth defects surveillance: assessing the "gold standard". Am J Public Health 89:1238-1240.
30. Honein MA, Paulozzi LJ, Moore CA. 2000. Family history, maternal smoking, and clubfoot: an indication of a gene-environment interaction. Am J Epidemiol 152:658-665.
31. Itikala PR, Watkins ML, Mulinare J, Moore CA, Liu Y. 2001. Maternal multivitamin use and orofacial clefts in offspring. Teratology 63:79-86.
32. International Clearinghouse for Birth Defects Monitoring Systems (ICB-DMS). 2002. Annual report 2002. Rome: International Centre for Birth Defects.
33. Khoury MJ, Waters G, Erickson JD. 1991. Patterns and trends of multiple congenital anomalies in birth defects surveillance systems. Teratology 44:57-64.
34. Khoury MJ, Edmonds LD. 1992. Metropolitan Congenital Defects Program: 25 years of birth defects surveillance at the Centers for Disease Control. In: Maistrocovo P, editor Proceedings of the III ASM International Symposium on Birth Defects, Rome, Italy, December 3-5, 1992. Rome: ICARO-ASM Press House, pp.1-7.
35. Khoury MJ, Moore CA, Mulinare J. 1996. Vitamin A and birth defects. Lancet 347:322.
36. Layde PM, Edmonds LD, Erickson JD. 1980. Maternal fever and neural tube defects. Teratology 21:105-108.
37. Lucas JM. 1985. Counted data cusums. Technometrics 27:129-144.
38. Lynberg MC, Chavez GF, Edmonds LD, Mulinare J. 1993. Evaluation of the birth defects monitoring program, 1982-1985. Teratology 48:650-657.
39. Lynberg MC, Khoury MJ, Lu X, Cocian T. 1994. Maternal flu, fever, and the risk of neural tube defects: a population based case-control study. Am J Epidemiol 140:244-245.
40. MacLeod PM. 1993. Implication of the child with malformations for the family and society. In: Stevenson RE, Hall JG, Goodman RM, editors. Human malformations and related anomalies. Vol. I. Oxford Monographs on Medical Genetics No. 27. Oxford University Press, pp. 187-196.
41. Miller JR. 1977. Birth defects monitoring systems: an overview. Congenital Anomalies 17:1-12.
42. Milunski A, Jick H, Jick SS, et al. 1989. Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects. JAMA 262:2847-2852.
43. MRC Vitamin Study Research Group. 1991. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 338:131-137.
44. Moore CA, Khoury MJ, Liu Y. 1997. Does light-to-moderate alcohol consumption during pregnancy increase the risk for renal anomalies among offspring? Pediatrics 99:E11.
45. Mulinare J, Cordero JF, Erickson JD, Berry RJ. 1988. Periconceptional use of multivitamins and the occurrence of neural tube defects. JAMA 260:3141-3145.
46. Myers M, Li S, Correa A, Li Z, Moore C, Xin-Hong S, Berry RJ, Wong H, Erickson DJ, and the China-US Collaborative Project for Neural Tube Defect Prevention. 2001. Prevention of imperforate anus with folic acid in China. Am J Epidemiol 154:1051-1056
47. National Birth Defect Prevention Network (NBDPN). 2000. Congenital malformations surveillance report. Teratology 61:86-158.
48. National Birth Defect Prevention Network (NBDPN). 2001. Congenital malformations surveillance report. Teratology 64(supplement 1):S117-S175.
49. National Birth Defect Prevention Network (NBDPN). 2002. Congenital malformations surveillance report. Teratology 66:S129-S211.
50. Oakley GP Jr. 1986. Frequency of human congenital malformations. Clin Perinatol 13:545-554.
51. Olney RS, Khoury MJ, Alo CJ, Costa P, Edmonds LD, Flood TJ, Harris JA, Howe HL, Moore CA, Olsen CL, Panny SR, Shaw GM. 1995. Increased risk for transverse digital deficiency after chorionic villus sampling: results of the United States Multistate Case-Control Study, 1988-1992. Teratology 51:20-29.
52. Paulozzi LJ, Erickson JD, Jackson RJ. 1997. Hypospadias trends in two U.S. surveillance systems. Pediatrics 100(5):831-834.
53. Petrini J, Damus, K, Russell R, Poschman K, Davidoff MJ, Mattison D. Contribution of birth defects to infant mortality in the United States. 2002. Teratology 66:S3-S6.
54. Rachelefalsy GS, Flynt SW, Ebbins AJ, Wilson MG. 1972. Possible teratogenicity of tricyclic antidepressants. Lancet i:838.
55. Roberts HE, Moore CA, Cragan JD, Fernhoff PM, Khoury MJ. 1995. Impact of prenatal diagnosis on the birth prevalence of neural tube defects, Atlanta, 1990-1991. Pediatrics 96:880-883.
56. Rosano A, Botto LD, Botting B, Mastroiacovo P. 2000. Infant mortality and congenital anomalies from 1950 to 1994: an international perspective. J Epidemiol Community Health 54:660-666.
57. Safra MJ, Oakley GP Jr. 1975. Association between cleft lip with or without cleft palate and prenatal exposure to diazepam. Lancet 2:478-480.
58. Safra MJ, Oakley GP Jr. 1976. Valium: an oral cleft teratogen? Cleft Palate Craniofac J 13:198-200.
59. Siffel C, Wong, L-Y, Olney RS, Correa A. 2003. Survival of infants with encephalocele in Atlanta, 1979-1998. Paediatr Perinat Epidemiol 17(1): 40-48.
60. Smithells RW, Shepard S, Schorah CJ, Seller MJ, Nevin NC, Harris R, Read AP, Fielding DW. 1980. Possible prevention of neural tube defects by periconconceptional vitamin supplementation. Lancet 1:339-340.
61. Smithells RW, Nevin NC, Seller MJ, Sheppard S, Harris R, Read AP, Fielding DW, Walker S, Schorah CJ, Wild J. 1983. Further experience of vitamin supplementation for prevention of neural tube defect recurrences. Lancet 1:1027-1031.
62. Spranger J, Benirscke K, Hall JG, Lenz W, Lowry RB, Opitz JM, Pinsky L. 1982. Errors of morphogenesis: concepts and terms. Recommendations of an international working group. J Pediatr 100:160-165.
63. Stevenson RE, Hall JG. 1993. Terminology. In: Stevenson RE, Hall JG, Goodman RM, editors. Human malformations and related anomalies. Vol. I. Oxford Monographs on Medical Genetics No. 27. Oxford University Press, pp. 21-30.
64. Sylvester GC, Khoury MJ, Lu X, Erickson JD. 1994. First-trimester anesthesia exposure and the risk of central nervous system defects: a population-based case-control study. Am J Public Health 84:1757-1760.
65. Watkins ML, Scanlon KS, Mulinare J, Khoury MJ. 1996. Is maternal obesity a risk factor for anencephaly and spina bifida? Epidemiology 7:507-512.
66. Watkins ML, Botto LD. 2001. Maternal prepregnancy weight and congenital heart defects in the offspring. Epidemiology 12:439-446.
67. Werler MM, Cragan JD, Wasserman CR, Shaw GM, Erickson JD, Mitchell AA. 1997. Multivitamin supplementation and multiple births. Am J Med Genet 71:93-96.
68. th Revision. Geneva; World Health Organization.
69. Williams LJ, Mai CT, Edmonds LD, Shaw GM, Kirby RS, Hobbs CA, Sever LE, Miller LA, Meaney FJ, Levitt M. 2002. Prevalence of spina bifida and anencephaly during the transition to mandatory folic acid fortification in the United States. Teratology 66:33-39.
70. Windham GC, Edmonds LD. 1982. Current trends in the incidence of neural tube defects. Pediatrics 70:333-337.
71. Wong L-YC, Paulozzi LJ. 2001. Survival of infants with spina bifida: a population study, 1979-94. Paediatric Perinatal Epidemiology 15:374-378.
72. Yang Q, Khoury MJ, Olney RS, Mulinare J. 1997. Does periconceptional multivitamin use reduce the risk for limb deficiency in offspring? Epidemiology 8:157-161.
73. Yang Q, Sherman SL, Hassold TJ, Allran K, Taft L, Pettay D, Khoury MJ, Erickson JD, Freeman SB. 1999. Risk factors for trisomy 21: maternal cigarette smoking and oral contraceptive use in a population-based case-control study. Genet Med 1:80-88.
74. Yen IH, Khoury MJ, Erickson JD, James LM, Waters GD, Berry RJ. 1992. The changing epidemiology of neural tube defects: United States, 1968-1989. Am J Dis Child 146:857-861.
75. Yoon PW, Olney RS, Khoury MJ, Sappenfield WM, Chavez GF, Taylor D. 1997. Contribution of birth defects and genetic diseases to pediatric hospitalizations. A population-based study. Arch Pediatr Adolesc Med 151:1096-1103.
76. Yoon PW, Rasmussen SA, Lynberg MC, Moore, CM, Anderra M, Carmichael SI, Costa P, Druschel C, Hobbs CA, Romitti PA, Langlois PH, Edmonds LD. 2001. The National Birth Defects Prevention Study. Pub Health Reports 116, S1:32-40.